Beginning in seven months, the new federal legislation will make Canadians with some mental illnesses, including treatment-resistant depression, eligible for medical assistance in dying (MAiD). However, the government is urged to consider amending the Controlled Drugs and Substances Act to allow psychedelic-assisted therapies, such as psilocybin therapy, which has shown promising results in treating mental illnesses.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
